HighTower Advisors LLC Has $718,000 Position in DENTSPLY SIRONA Inc. (XRAY)

HighTower Advisors LLC lifted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 62.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,061 shares of the medical instruments supplier’s stock after purchasing an additional 4,238 shares during the period. HighTower Advisors LLC’s holdings in DENTSPLY SIRONA were worth $718,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Veritas Asset Management LLP lifted its stake in shares of DENTSPLY SIRONA by 2.6% in the 2nd quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock valued at $402,083,000 after purchasing an additional 157,616 shares during the last quarter. Bronfman E.L. Rothschild L.P. lifted its stake in shares of DENTSPLY SIRONA by 78.7% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 11,886 shares of the medical instruments supplier’s stock valued at $771,000 after purchasing an additional 5,236 shares during the last quarter. Royce & Associates LP lifted its stake in shares of DENTSPLY SIRONA by 23.4% in the 2nd quarter. Royce & Associates LP now owns 126,650 shares of the medical instruments supplier’s stock valued at $8,212,000 after purchasing an additional 24,000 shares during the last quarter. Gateway Investment Advisers LLC lifted its stake in shares of DENTSPLY SIRONA by 8.4% in the 2nd quarter. Gateway Investment Advisers LLC now owns 19,408 shares of the medical instruments supplier’s stock valued at $1,258,000 after purchasing an additional 1,499 shares during the last quarter. Finally, Delta Lloyd Asset Management N.V. bought a new position in DENTSPLY SIRONA in the 2nd quarter worth $15,624,000. 93.88% of the stock is owned by institutional investors and hedge funds.

XRAY has been the topic of several recent analyst reports. BidaskClub upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, June 30th. HC Wainwright initiated coverage on shares of DENTSPLY SIRONA in a report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 target price on the stock. Credit Suisse Group reiterated an “outperform” rating and issued a $75.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Thursday, July 13th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 target price on the stock in a report on Thursday, July 13th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $66.00 target price (down previously from $70.00) on shares of DENTSPLY SIRONA in a report on Thursday, August 10th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $65.89.

COPYRIGHT VIOLATION NOTICE: This news story was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this news story on another site, it was copied illegally and reposted in violation of US and international trademark and copyright law. The correct version of this news story can be viewed at https://ledgergazette.com/2017/10/15/hightower-advisors-llc-has-718000-position-in-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 58.22 on Friday. DENTSPLY SIRONA Inc. has a 12-month low of $52.54 and a 12-month high of $65.68. The stock’s 50 day moving average is $57.94 and its 200 day moving average is $61.08. The company’s market cap is $13.36 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting ana

Other hedge funds have also added to or reduced their stakes in the company. Veritas Asset Management LLP lifted its stake in shares of DENTSPLY SIRONA by 2.6% in the 2nd quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock valued at $402,083,000 after purchasing an additional 157,616 shares during the last quarter. Bronfman E.L. Rothschild L.P. lifted its stake in shares of DENTSPLY SIRONA by 78.7% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 11,886 shares of the medical instruments supplier’s stock valued at $771,000 after purchasing an additional 5,236 shares during the last quarter. Royce & Associates LP lifted its stake in shares of DENTSPLY SIRONA by 23.4% in the 2nd quarter. Royce & Associates LP now owns 126,650 shares of the medical instruments supplier’s stock valued at $8,212,000 after purchasing an additional 24,000 shares during the last quarter. Gateway Investment Advisers LLC lifted its stake in shares of DENTSPLY SIRONA by 8.4% in the 2nd quarter. Gateway Investment Advisers LLC now owns 19,408 shares of the medical instruments supplier’s stock valued at $1,258,000 after purchasing an additional 1,499 shares during the last quarter. Finally, Delta Lloyd Asset Management N.V. bought a new position in DENTSPLY SIRONA in the 2nd quarter worth $15,624,000. 93.88% of the stock is owned by institutional investors and hedge funds.

XRAY has been the topic of several recent analyst reports. BidaskClub upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, June 30th. HC Wainwright initiated coverage on shares of DENTSPLY SIRONA in a report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 target price on the stock. Credit Suisse Group reiterated an “outperform” rating and issued a $75.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a report on Thursday, July 13th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 target price on the stock in a report on Thursday, July 13th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $66.00 target price (down previously from $70.00) on shares of DENTSPLY SIRONA in a report on Thursday, August 10th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $65.89.

COPYRIGHT VIOLATION NOTICE: This news story was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this news story on another site, it was copied illegally and reposted in violation of US and international trademark and copyright law. The correct version of this news story can be viewed at https://ledgergazette.com/2017/10/15/hightower-advisors-llc-has-718000-position-in-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 58.22 on Friday. DENTSPLY SIRONA Inc. has a 12-month low of $52.54 and a 12-month high of $65.68. The stock’s 50 day moving average is $57.94 and its 200 day moving average is $61.08. The company’s market cap is $13.36 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.65. The company had revenue of $992.70 million during the quarter, compared to analysts’ expectations of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. DENTSPLY SIRONA’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.76 EPS. On average, equities analysts forecast that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply